Assertio Holdings, Inc. (ASRT)
After hours:
| Previous close | 1.0500 |
| Open | 1.0300 |
| Bid | 0.9564 x 200 |
| Ask | 0.9702 x 400 |
| Day's range | 0.9500 - 1.0500 |
| 52-week range | 0.7300 - 7.5800 |
| Volume | |
| Avg. volume | 1,022,233 |
| Market cap | 91.32M |
| Beta (5Y monthly) | 1.00 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -4.6500 |
| Earnings date | 01 Aug 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 3.00 |
GlobeNewswireAssertio to Present at the Citizens JMP Life Sciences Conference in New York City
LAKE FOREST, Ill., May 10, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, today announced that Ajay Patel, Chief Financial Officer, will present at the Citizens JMP Life Sciences Conference to be held May 13, 2024 in New York City. The Company will host a group presentation at 12:00 pm Eastern Time, and be available for individual meeti
Simply Wall St.Assertio Holdings First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Assertio Holdings ( NASDAQ:ASRT ) First Quarter 2024 Results Key Financial Results Revenue: US$32.4m (down 24% from 1Q...
Insider MonkeyAssertio Holdings, Inc. (NASDAQ:ASRT) Q1 2024 Earnings Call Transcript
Assertio Holdings, Inc. (NASDAQ:ASRT) Q1 2024 Earnings Call Transcript May 6, 2024 Assertio Holdings, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, and welcome to Assertio Holdings First Quarter 2024 Financial Results Call. [Operator Instructions] I would […]
